Periodontal Therapeutics Market: Systemic Antibiotics to Surface as Most Valued Product
With a few players holding a massive market share, the global periodontal therapeutics market displays an extremely consolidated competitive landscape, states a new study by Transparency Market Research (TMR). In 2015, the leading participants, namely, 3M, Valeant Pharmaceuticals Int. Inc., and Den-Mat Holdings, acquired a share of 77.7% in the overall market. The leading companies are focusing on research and development of therapies and, for which, they are investing heavily in this market. This, as a result, is expected to...
View full press release